scholarly journals Critical Role of the Ubiquitin Ligase Activity of UHRF1, a Nuclear RING Finger Protein, in Tumor Cell Growth

2005 ◽  
Vol 16 (12) ◽  
pp. 5621-5629 ◽  
Author(s):  
Yonchu Jenkins ◽  
Vadim Markovtsov ◽  
Wayne Lang ◽  
Poonam Sharma ◽  
Denise Pearsall ◽  
...  

Early cellular events associated with tumorigenesis often include loss of cell cycle checkpoints or alteration in growth signaling pathways. Identification of novel genes involved in cellular proliferation may lead to new classes of cancer therapeutics. By screening a tetracycline-inducible cDNA library in A549 cells for genes that interfere with proliferation, we have identified a fragment of UHRF1 (ubiquitin-like protein containing PHD and RING domains 1), a nuclear RING finger protein, that acts as a dominant negative effector of cell growth. Reduction of UHRF1 levels using an UHRF1-specific shRNA decreased growth rates in several tumor cell lines. In addition, treatment of A549 cells with agents that activated different cell cycle checkpoints resulted in down-regulation of UHRF1. The primary sequence of UHRF1 contains a PHD and a RING motif, both of which are structural hallmarks of ubiquitin E3 ligases. We have confirmed using an in vitro autoubiquitination assay that UHRF1 displays RING-dependent E3 ligase activity. Overexpression of a GFP-fused UHRF1 RING mutant that lacks ligase activity sensitizes cells to treatment with various chemotherapeutics. Taken together, our results suggest a general requirement for UHRF1 in tumor cell proliferation and implicate the RING domain of UHRF1 as a functional determinant of growth regulation.

2012 ◽  
Vol 287 (15) ◽  
pp. 12158-12158
Author(s):  
Hezlin Marzook ◽  
Da-Qiang Li ◽  
Vasudha S. Nair ◽  
Prakriti Mudvari ◽  
Sirigiri Divijendra Natha Reddy ◽  
...  

2002 ◽  
Vol 7 (8) ◽  
pp. 835-850 ◽  
Author(s):  
Takeshi Akasaka ◽  
Naomi Takahashi ◽  
Maki Suzuki ◽  
Haruhiko Koseki ◽  
Rolf Bodmer ◽  
...  

2011 ◽  
Vol 287 (8) ◽  
pp. 5615-5626 ◽  
Author(s):  
Hezlin Marzook ◽  
Da-Qiang Li ◽  
Vasudha S. Nair ◽  
Prakriti Mudvari ◽  
Sirigiri Divijendra Natha Reddy ◽  
...  

2015 ◽  
Vol 290 (11) ◽  
pp. 6751-6751 ◽  
Author(s):  
Hezlin Marzook ◽  
Da-Qiang Li ◽  
Vasudha S. Nair ◽  
Prakriti Mudvari ◽  
Sirigiri Divijendra Natha Reddy ◽  
...  

2005 ◽  
Vol 23 (36) ◽  
pp. 9408-9421 ◽  
Author(s):  
Gary K. Schwartz ◽  
Manish A. Shah

The cell cycle represents a series of tightly integrated events that allow the cell to grow and proliferate. Critical parts of the cell cycle machinery are the cyclin-dependent kinases (CDKs), which, when activated, provide a means for the cell to move from one phase of the cell cycle to the next. The CDKs are regulated positively by cyclins and regulated negatively by naturally occurring CDK inhibitors (CDKIs). Cancer represents a dysregulation of the cell cycle such that cells that overexpress cyclins or do not express the CDKIs continue to undergo unregulated cell growth. The cell cycle also serves to protect the cell from DNA damage. Thus, cell cycle arrest, in fact, represents a survival mechanism that provides the tumor cell the opportunity to repair its own damaged DNA. Thus, abrogation of cell cycle checkpoints, before DNA repair is complete, can activate the apoptotic cascade, leading to cell death. Now in clinical trials are a series of targeted agents that directly inhibit the CDKs, inhibit unrestricted cell growth, and induce growth arrest. Recent attention has also focused on these drugs as inhibitors of transcription. In addition, there are now agents that abrogate the cell cycle checkpoints at critical time points that make the tumor cell susceptible to apoptosis. An understanding of the cell cycle is critical to understanding how best to clinically develop these agents, both as single agents and in combination with chemotherapy.


2016 ◽  
Vol 6 (1) ◽  
Author(s):  
Changping Ma ◽  
Huibin Song ◽  
Lei Yu ◽  
Kaifeng Guan ◽  
Pandi Hu ◽  
...  

Endocrinology ◽  
2004 ◽  
Vol 145 (5) ◽  
pp. 2433-2444 ◽  
Author(s):  
Sirpa J. Hirvonen-Santti ◽  
Venkataraman Sriraman ◽  
Mikko Anttonen ◽  
Saija Savolainen ◽  
Jorma J. Palvimo ◽  
...  

2015 ◽  
Vol 112 (35) ◽  
pp. E4854-E4863 ◽  
Author(s):  
Elisa Aguilar-Martinez ◽  
Xi Chen ◽  
Aaron Webber ◽  
A. Paul Mould ◽  
Anne Seifert ◽  
...  

Protein SUMOylation has emerged as an important regulatory event, particularly in nuclear processes such as transcriptional control and DNA repair. In this context, small ubiquitin-like modifier (SUMO) often provides a binding platform for the recruitment of proteins via their SUMO-interacting motifs (SIMs). Recent discoveries point to an important role for multivalent SUMO binding through multiple SIMs in the binding partner as exemplified by poly-SUMOylation acting as a binding platform for ubiquitin E3 ligases such as ring finger protein 4. Here, we have investigated whether other types of protein are recruited through multivalent SUMO interactions. We have identified dozens of proteins that bind to multi-SUMO platforms, thereby uncovering a complex potential regulatory network. Multi-SUMO binding is mediated through multi-SIM modules, and the functional importance of these interactions is demonstrated for the transcriptional corepressor ZMYM2/ZNF198 where its multi-SUMO–binding activity is required for its recruitment to chromatin.


2000 ◽  
Vol 113 (17) ◽  
pp. 2991-3001 ◽  
Author(s):  
H. Poukka ◽  
U. Karvonen ◽  
N. Yoshikawa ◽  
H. Tanaka ◽  
J.J. Palvimo ◽  
...  

The androgen receptor (AR) is a transcription factor that mediates androgen action. We have used the green fluorescent protein (GFP) technique to investigate dynamics of nuclear trafficking of human AR in living cells. In the absence of ligand, the GFP-AR fusion protein is distributed between cytoplasm and nuclei. Androgen exposure leads to a rapid and complete import of GFP-AR to nuclei of CV-1 cells (>=90% nuclear in 30 minutes), whereas a pure antiandrogen, Casodex, elicits a slower (<40% nuclear in 30 minutes) and incomplete transfer. Unliganded ARs with mutations in the basic amino acids of the bipartite nuclear localization signal (NLS) within the second zinc finger and the hinge region are predominantly cytoplasmic and their androgen-dependent nuclear import is severely compromised ((3/4)20% nuclear in 30 minutes). Interestingly, substitutions of the Leu residues flanking the bipartite NLS lead to inefficient nuclear transfer in response to androgen ((3/4)20% nuclear in 30 minutes). The ligand-binding domain of AR, which represses bipartite NLS activity, contains an agonist-specific NLS. The small nuclear RING finger protein SNURF, which interacts with AR through a region overlapping with the bipartite NLS, facilitates AR import to nuclei and retards its export on hormone withdrawal. More AR is associated with the nuclear matrix in the presence than absence of coexpressed SNURF. We suggest that the SNURF-mediated tethering of AR in nuclei represents a novel mechanism for activating steroid receptor functions.


Sign in / Sign up

Export Citation Format

Share Document